Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-01-06 Sale |
2025-01-06 8:34 pm |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO |
57,291 | $14.92 | $855,017 | 261,805 (Direct) |
View |
2024-01-05 Sale |
2024-01-08 6:23 pm |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO |
23,904 | $10.79 | $257,845 | 619,096 (Direct) |
View |
2020-09-09 Sale |
2020-09-10 4:44 pm |
MACROGENICS INC | MGNX | Galbraith Kenneth Director |
20,773 | $27.11 | $563,156 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-10 Option Award |
2025-01-10 5:58 pm |
N/A 2035-01-09 |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO |
480,000 | $0 | 480,000 (Direct) |
View |
2025-01-06 Exercise |
2025-01-06 8:34 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO |
114,332 | $0 | 261,805 (Direct) |
View |
2024-01-05 Option Award |
2024-01-08 6:23 pm |
N/A 2034-01-04 |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO |
500,000 | $0 | 619,096 (Direct) |
View |
2024-01-05 Exercise |
2024-01-08 6:23 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO |
47,666 | $0 | 619,096 (Direct) |
View |
2023-01-05 Option Award |
2023-01-06 8:00 pm |
N/A 2033-01-04 |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO |
358,000 | $0 | 358,000 (Direct) |
View |
2022-12-22 Option Award |
2022-12-23 7:30 pm |
2025-12-22 2025-12-22 |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO |
100,000 | $0 | 100,000 (Direct) |
View |
2022-01-15 Option Award |
2022-01-18 06:25 am |
N/A 2032-01-14 |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair, President & CEO |
500,000 | $0 | 500,000 (Direct) |
View |
2021-05-13 Option Award |
2021-05-17 9:20 pm |
N/A 2031-05-13 |
MACROGENICS INC | MGNX | Galbraith Kenneth Director |
15,000 | $0 | 15,000 (Direct) |
View |
2020-09-09 Exercise |
2020-09-10 4:44 pm |
N/A 2023-10-09 |
MACROGENICS INC | MGNX | Galbraith Kenneth Director |
20,773 | $0 | 0 (Direct) |
View |
2020-09-09 Exercise |
2020-09-10 4:44 pm |
N/A N/A |
MACROGENICS INC | MGNX | Galbraith Kenneth Director |
13,849 | $16 | 0 (Direct) |
View |
2020-09-09 Exercise |
2020-09-10 4:44 pm |
N/A N/A |
MACROGENICS INC | MGNX | Galbraith Kenneth Director |
6,924 | $20.15 | 0 (Direct) |
View |
2020-05-14 Option Award |
2020-05-15 4:36 pm |
N/A 2030-05-14 |
MACROGENICS INC | MGNX | Galbraith Kenneth Director |
15,000 | $0 | 15,000 (Direct) |
View |